What are generic & biosimilar medicine manufacturers doing to expand access to their products? скачать в хорошем качестве

What are generic & biosimilar medicine manufacturers doing to expand access to their products?

The generics industry plays a critical role in widening access to medicine globally, primarily by manufacturing off-patent medicines at high volumes and supplying them at lower costs than the original patented medicines. Yet, many people, especially in low- and middle-income countries, still lack affordable and reliable access to quality-assured essential medicines. To address this, the world’s leading producers of generic and biosimilar medicines can use their position in the global health landscape to expand access to essential medicines. Our Research Programme Manager and Researcher for the Generic & Biosimilar Medicines Programme, Claudia Martínez and Danielle Barnum, announce the publication of the report that profiles five major players in the generic and biosimilar medicines industry and identifies what steps they are currently taking on key access-to-medicine priorities. Learn more about our Generic & Biosimilar Medicines Programme 👉 https://accesstomedicinefoundation.or... Visit our website 👉 https://accesstomedicinefoundation.org/ Follow us on social media: Twitter 👉   / atmindex   LinkedIn 👉   / access-to-medicine-foundation   #GenericDrugs #generics #biosimilars #AccesstoMedicine #AccesstoHealthcare #EquitableAccess